Over the last few years, an increase in awareness of indications for pacemakers (PMs) and especially implantable cardioverter defibrillators (ICDs) has led to steady growth in the number of patients with implantable devices. That said, follow-up appointments are necessary after implantation to provide individualized treatment and to detect malfunctions. According to the recent ACC/AHA/HRS guidelines, patients with a PM are advised to attend follow-up appointments every 3-12 months, while those with an ICD every 3-6 months. The frequent patients’ consulting results in a significant increase in workload for outpatient clinics.
From Transtelephonic monitoring to smartphone apps, the technological innovation in the remote cardiac monitoring field has been fabulous over the years. The trend in electrophysiology toward the use of advanced remote monitoring of implantable devices such as cardioverter defibrillators (ICDs), cardiac monitors (ICMs), and more has gained significant traction. Yet millions of patients with cardiac implantable devices worldwide are still not telemonitored despite the clinical evidence on benefits because remote cardiac monitoring is a time-consuming and complex process. “Remote monitoring has been shown to decrease patient morbidity and mortality by providing early warning of cardiac problems and alleviate the volume of in-office patient follow-ups, which allow physicians to monitor more patients,” begins Dr. Arnaud Rosier, Founder, and CEO of Implicity